These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19684638)

  • 1. Glutathione S-transferase T1 is a potential new target for the hepatic component of graft vs host disease after HSCT.
    Aguilera I; Espigado I; Martinez-Bravo MJ; Tallon I; Urbano-Ispizua A; Nuñez-Roldan A
    Bone Marrow Transplant; 2010 Apr; 45(4):774-5. PubMed ID: 19684638
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease.
    Martínez-Bravo MJ; Tallón I; Espigado I; Perez-Simón JA; Pérez-Romero P; Gracia-Ahufinger I; Aguilera I; Núñez-Roldán A
    Immunol Lett; 2011 Dec; 141(1):140-4. PubMed ID: 21968078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
    Kim I; Keam B; Lee KH; Kim JH; Oh SY; Ra EK; Yoon SS; Park SS; Kim CS; Park S; Hong YC; Kim BK
    Clin Transplant; 2007; 21(2):207-13. PubMed ID: 17425746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against glutathione S-transferase T1 in non-solid organ transplanted patients.
    Wichmann I; Aguilera I; Sousa JM; Bernardos A; García Núñez EJ; Vigil E; Magariño R; Magariño I; Torres A; Núñez-Roldán A
    Transfusion; 2006 Sep; 46(9):1505-9. PubMed ID: 16965576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients.
    Choi IC; Fung PC; Leung AY; Lie AK; Liang R
    Haematologica; 2001 Sep; 86(9):972-6. PubMed ID: 11532626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
    Loren AW; Bunin GR; Boudreau C; Champlin RE; Cnaan A; Horowitz MM; Loberiza FR; Porter DL
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):758-69. PubMed ID: 16785065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch.
    Nakai K; Mineishi S; Kami M; Kanda Y; Tanosaki R; Takaue Y
    Haematologica; 2003 Jan; 88(1):115-7. PubMed ID: 12551837
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloimmune response against donor glutathione S-transferase T1 antigen in renal transplant recipients.
    Aguilera I; Wichmann I; Gentil MA; Gonzalez-Escribano F; Nuñez-Roldan A
    Am J Kidney Dis; 2005 Aug; 46(2):345-50. PubMed ID: 16112055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of GSTT1 mismatch in solid organ and hematopoietic stem cell transplantation.
    Aguilera I; Sousa JM; Núñez-Roldán A
    Hum Immunol; 2013 Nov; 74(11):1470-3. PubMed ID: 23792056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
    Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
    Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL-6 gene polymorphism with the outcome of allogeneic haematopoietic stem cell transplantation in Czech patients.
    Ambruzova Z; Mrazek F; Raida L; Faber E; Onderkova J; Kriegova E; Indrak K; Petrek M
    Int J Immunogenet; 2008 Aug; 35(4-5):401-3. PubMed ID: 18976446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
    Mori S; El-Baki H; Mullen CA
    Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
    Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
    Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Remberger M
    Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.